title: [COPE trial].
authors.affiliation: Pharmaceutical Clinical Research Center, Yamaguchi University Hospital.
authors.forename: Seiji
authors.initials: S
authors.lastname: Umemoto
authors.forename: Akira
authors.initials: A
authors.lastname: Kamiya
authors.forename: Masunori
authors.initials: M
authors.lastname: Matsuzaki
authors.forename: Toshio
authors.initials: T
authors.lastname: Ogihara
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D004095:Dihydropyridines / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007564:Japan; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D049993:Sodium Chloride Symporter Inhibitors; C061004:benidipine